Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthy Body, Healthy Bones Trial
NCT04279392Phase 2Completed
- Sponsor
- University of Nebraska
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in osteoporosis, sponsored by University of Nebraska. Started Sep 2020; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04279392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04279392.